Pre-made Dorlimomab Aritox benchmark antibody (ADC, anti-40S ribosomal protein S18 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-805

Pre-made Dorlimomab Aritox benchmark antibody (ADC, anti-40S ribosomal protein S18 therapeutic antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-805-1mg 1mg Inquiry
GMP-Bios-INN-805-10mg 10mg Inquiry
GMP-Bios-INN-805-100mg 100mg Inquiry
GMP-Bios-INN-805-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Dorlimomab Aritox Biosimilar, Whole Mab Adc: Anti-40S Ribosomal Protein S18 therapeutic antibody
INN Name Dorlimomab Aritox
Target40S ribosomal protein S18
FormatADC
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeF(ab')2 - nd - nd
VD LCF(ab')2 - nd - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesMedarex (Princeton NJ USA) / Houston Biotechnology (The Woodlands TX USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0